Sierk Poetting sold $5.5M of BioNTech SE (BNTX)

Executed Apr 22, disclosed Apr 23, 1 day later.

Value, as filed

$5.5M

50,000 sh × $110.56

Executed

Apr 22

the trade date, as filed

Disclosed

Apr 23

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SP Sierk Poetting Chief Operating Officer profile →

Sierk Poetting (Chief Operating Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioNTech SE (BNTX). The largest single filing was $5.5M of BNTX (50,000 sh × $110.56, as filed), executed Apr 22.

The name

BNTX BioNTech SE BNTX · Healthcare · 9 filings in 24 months ticker →

Healthcare · BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→